Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

149 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The RUNX genes: gain or loss of function in cancer.
Blyth K, Cameron ER, Neil JC. Blyth K, et al. Among authors: neil jc. Nat Rev Cancer. 2005 May;5(5):376-87. doi: 10.1038/nrc1607. Nat Rev Cancer. 2005. PMID: 15864279 Review.
Runx2 in normal tissues and cancer cells: A developing story.
Blyth K, Vaillant F, Jenkins A, McDonald L, Pringle MA, Huser C, Stein T, Neil J, Cameron ER. Blyth K, et al. Blood Cells Mol Dis. 2010 Aug 15;45(2):117-23. doi: 10.1016/j.bcmd.2010.05.007. Epub 2010 Jun 26. Blood Cells Mol Dis. 2010. PMID: 20580290
Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.
Baxter EW, Blyth K, Cameron ER, Neil JC. Baxter EW, et al. Among authors: neil jc. J Virol. 2001 Oct;75(20):9790-8. doi: 10.1128/JVI.75.20.9790-9798.2001. J Virol. 2001. PMID: 11559812 Free PMC article.
p53 and tumour viruses: catching the guardian off-guard.
Neil JC, Cameron ER, Baxter EW. Neil JC, et al. Trends Microbiol. 1997 Mar;5(3):115-20. doi: 10.1016/S0966-842X(96)10083-4. Trends Microbiol. 1997. PMID: 9080610 Review.
Skewed T-cell receptor Vbeta8.2 expression in transgenic CD2-myc induced thymic lymphoma: a role for antigen stimulation in tumour development?
Webster G, Onions DE, Neil JC, Cameron ER. Webster G, et al. Among authors: neil jc. Br J Cancer. 1997;76(6):739-46. doi: 10.1038/bjc.1997.455. Br J Cancer. 1997. PMID: 9310239 Free PMC article.
Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral tagging.
Blyth K, Terry A, Mackay N, Vaillant F, Bell M, Cameron ER, Neil JC, Stewart M. Blyth K, et al. Among authors: neil jc. Oncogene. 2001 Jan 18;20(3):295-302. doi: 10.1038/sj.onc.1204090. Oncogene. 2001. PMID: 11313958
Fas-independent apoptosis in T-cell tumours induced by the CD2-myc transgene.
Cameron ER, Morton J, Johnston CJ, Irvine J, Bell M, Onions DE, Neil JC, Campbell M, Blyth K. Cameron ER, et al. Among authors: neil jc. Cell Death Differ. 2000 Jan;7(1):80-8. doi: 10.1038/sj.cdd.4400630. Cell Death Differ. 2000. PMID: 10713723
Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): evidence for a new myc collaborating oncogene.
Stewart M, Terry A, Hu M, O'Hara M, Blyth K, Baxter E, Cameron E, Onions DE, Neil JC. Stewart M, et al. Among authors: neil jc. Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8646-51. doi: 10.1073/pnas.94.16.8646. Proc Natl Acad Sci U S A. 1997. PMID: 9238031 Free PMC article.
Apparent bypass of negative selection in CD8+ tumours in CD2-myc transgenic mice.
Cameron ER, Campbell M, Blyth K, Argyle SA, Keanie L, Neil JC, Onions DE. Cameron ER, et al. Among authors: neil jc. Br J Cancer. 1996 Jan;73(1):13-7. doi: 10.1038/bjc.1996.3. Br J Cancer. 1996. PMID: 8554976 Free PMC article.
Conditional expression and oncogenicity of c-myc linked to a CD2 gene dominant control region.
Stewart M, Cameron E, Campbell M, McFarlane R, Toth S, Lang K, Onions D, Neil JC. Stewart M, et al. Among authors: neil jc. Int J Cancer. 1993 Apr 1;53(6):1023-30. doi: 10.1002/ijc.2910530628. Int J Cancer. 1993. PMID: 8473043
149 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback